Z-1066-2016 Class II Terminated
FDA device recall Z-1066-2016 was initiated by Philips Electronics North America Corporation on Oct 1, 2015 and is designated Class II. Reason for recall: Upon initiating Fluoroscopy the user may encounter a user message Fluoro failed. The recall status is terminated (terminated Oct 8, 2020). Affected quantity: 196 devices.
Recall details
- Product Type
- Devices
- Report Date
- Mar 16, 2016
- Initiation Date
- Oct 1, 2015
- Termination Date
- Oct 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 196 devices
Product description
Philips X-Ray Systems, Allura Xper with R8.2.16 Product Usage: The Allura Xper FD1O and Allura Xper FD1O/10 is intended for use in cardiovascular and vascular X-ray imaging applications, including diagnostic, interventional procedures (such as PTCA, stent placement and atherectomies), pacemaker implantations and Electrophysiology (EP). The Allura Xper FD2O, Allura Xper FD2O/10 and Allura Xper FD2O/20 is intended for: Dedicated vascular and neurovascular imaging applications, including diagnostic and interventional procedures.
Reason for recall
Upon initiating Fluoroscopy the user may encounter a user message Fluoro failed.
Distribution pattern
US Nationwide in the states of : AK, AL, AZ, CA, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, NJ, NY, OH, OR, PA, TN, TX, UT, WI, WV and the country of Canada.
Code information
Product Codes: 722026, 722027, 722028, 722029, 722033, 722034, 722035, 722036, 722038, 722039, 722058, 722059 systems with release R8.2.16
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1066-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026